BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9763145)

  • 1. Effect of clodronate treatment on established bone loss in ovariectomized rats.
    Kippo K; Hannuniemi R; Laurén L; Peng Z; Kuurtamo P; Virtamo T; Isaksson P; Osterman T; Väänänen HK; Sellman R
    Bone; 1998 Oct; 23(4):333-42. PubMed ID: 9763145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clodronate prevents bone loss in aged ovariectomized rats.
    Kippo K; Hannuniemi R; Laurén L; Peng Z; Isaksson P; Virtamo T; Osterman T; Pasanen I; Sellman R; Väänänen HK
    Calcif Tissue Int; 1997 Aug; 61(2):151-7. PubMed ID: 9236264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats.
    Lepola VT; Kippo K; Hannuniemi R; Laurén L; Virtamo T; Osterman T; Jalovaara P; Sellman R; Väänänen HK
    J Bone Miner Res; 1996 Oct; 11(10):1508-17. PubMed ID: 8889851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner.
    Mosekilde L; Thomsen JS; Orhii PB; Kalu DN
    Bone; 1998 Oct; 23(4):343-52. PubMed ID: 9763146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
    Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
    Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats.
    Kippo K; Hannuniemi R; Virtamo T; Laurén L; Ikävalko H; Kovanen V; Osterman T; Sellman R
    Bone; 1995 Dec; 17(6):533-42. PubMed ID: 8835307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
    Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
    J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
    Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
    Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment effects of bisphosphonates on ovariectomy-induced osteopenia in rats: comparison between clodronate and etidronate.
    Itoh F; Shiraki M; Komatsu H; Imai Y; Komatsu Y; Taya F; Kojima M
    J Bone Miner Metab; 1999; 17(4):252-8. PubMed ID: 10575589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clodronate on cortical and trabecular bone in ovariectomized rats on a low calcium diet.
    Kaastad TS; Reikerâs O; Madsen JE; Narum S; Stromme JH; Obrant KJ; Nordsletten L
    Calcif Tissue Int; 1997 Aug; 61(2):158-64. PubMed ID: 9236265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats.
    Ammann P; Bourrin S; Bonjour JP; Brunner F; Meyer JM; Rizzoli R
    Osteoporos Int; 1999; 10(5):369-76. PubMed ID: 10591834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Okubo R; Sanada LS; Castania VA; Louzada MJ; de Paula FJ; Maffulli N; Shimano AC
    Osteoporos Int; 2017 Apr; 28(4):1461-1471. PubMed ID: 28124728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats.
    Osterman T; Laurén L; Kuurtamo P; Hannuniemi R; Isaksson P; Kippo K; Peng Z; Väänänen HK; Sellman R
    J Pharmacol Exp Ther; 1998 Jan; 284(1):312-6. PubMed ID: 9435193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia.
    Li X; Takahashi M; Kushida K; Shimizu S; Hoshino H; Suzuki M; Inoue T
    J Bone Miner Metab; 2000; 18(5):258-63. PubMed ID: 10959614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.